Bortezomib Impurity 37

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Bortezomib Impurity 37 is a specified impurity associated with Bortezomib that may arise during synthesis or degradation. It has a slightly modified chemical structure compared to the active drug and is carefully monitored and controlled in pharmaceutical quality testing to ensure product safety, stability, and consistent therapeutic performance.

Head Office Address

Our Office Addresses